HopeStage
Back to all studies
Enrolling By InvitationNCT01088386

Zyprexa® Relprevv™ Patient Care Program

Observational studyAges 18+United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Blue BellSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 3, 2010
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
4,000
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT01088386
Official title
Show the full official title

Zyprexa® Relprevv™ Patient Care Program

Recruitment & locations

By invitation

Blue Bell

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies